Clinical Trial

HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria

Study acronym: ITEST-LAI
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as commercial minibus drivers who have minimal or no contact with traditional health facilities. The project proposes to use a culturally appropriate and community-engaged approach to promote the uptake of HIV self-testing, LAI-ART, and LAI-PrEP among commercial minibus drivers in Nigeria by engaging commercial minibus drivers as peer educators/research facilitators.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-24; most recent amendment 2026-05-13.
Trial Details
NCT Number NCT07000513
Lead Sponsor George Washington University
Collaborators: The George Washington University Milken Institute School of Public Health (GWU)
Conditions HIV
Enrollment 400 participants
Start Date 2027-02-01
Primary Completion 2029-02-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-15